Iris Wang, CFA

Founding Partner & Chief Investment Officer, TruMed Investment

Ms. Iris (Ting) Wang, CFA, is the Founding Partner and Chief Investment Officer of TruMed Investment. Prior to founding TruMed, Ms. Wang was a Partner of OrbiMed. Previously, Ms. Wang was a Director at Credit Suisse and head of the Asia and China healthcare research team. She started her professional career as a management consultant at McKinsey & Co. and A.T. Kearney, focusing on healthcare and supply chain management.

Ms. Wang is an M.B.A. degree holder from Columbia Business School, where she graduated with Dean’s Honor in the Value Investing Program in 2011. She also holds two B.S. degrees in Biological Science and Economics from Peking University and has taken major courses in the Department of Psychology.